Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 301–400 of 1,000
Nguyen, L., Lander, L. R., O’Grady, K. E., Marshalek, P. J., Schmidt, A., Kelly, A. K., & Jones, H. E. (2018) · American Journal on Addictions · doi:10.1111/ajad.12687 · Cited by 30
Self-citationMorphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome
Tolia, V. N., Murthy, K., Bennett, M., Greenberg, R. G., Benjamin, D. K., Smith, P. B., & Clark, R. H. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.07.061 · Cited by 30
Konijnenberg, C., Lund, I. O., & Melinder, A. M. D. (2015) · Early Child Development and Care · doi:10.1080/03004430.2015.1016506 · Cited by 30
Data Integrity Problems in an Open Hypermedia Link Service
Davis, H. (1995) · ePrints Soton (University of Southampton) · Cited by 30
Coyne, L., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.036 · Cited by 29
Hein, S., Clouser, B., Tamim, M. M., Lockett, D., Brauer, K., & Cooper, L. (2020) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000824 · Cited by 29
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant
Wouldes, T. A., & Lester, B. M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1305508 · Cited by 31
Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study
Mullins, N., Galvin, S. L., Ramage, M., Gannon, M., Lorenz, K., Sager, B., & Coulson, C. C. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000562 · Cited by 29
Tiako, M. J. N., Culhane, J. F., South, E. C., Srinivas, S. K., & Meisel, Z. F. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29043 · Cited by 28
Boardman, J. P., Mactier, H., & Devlin, L. A. (2021) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2020-320102 · Cited by 28
Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls
Mazel, S. B., Alexander, K., Cioffi, C. C., & Terplan, M. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s375652 · Cited by 28
Jones, H. E., Fitzsimons, Tuten, Chisolm, M. S., O`Grady, & Jones, H. E. (2012) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s26288 · Cited by 28
Self-citationNeonatal Abstinence Syndrome: Presentation and Treatment Considerations
Jones, H. E., Kaltenbach, K. A., Johnson, E., Seashore, C. J., Freeman, E. L., & Malloy, E. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000222 · Cited by 28
Self-citationSwain, J. E., & Ho, S.-H. S. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12770 · Cited by 28
Parenting and Concerns of Pregnant Women in Buprenorphine Treatment
Rizzo, R. A., Neumann, A. M., King, S. O., Hoey, R. F., Finnell, D. S., & Blondell, R. D. (2014) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0000000000000066 · Cited by 28
Bioanalysis During Pregnancy: Recent Advances and Novel Sampling Strategies
Concheiro‐Guisán, A., & Concheiro, M. (2014) · Bioanalysis · doi:10.4155/bio.14.278 · Cited by 28
Treating Opioid Use Disorders during Pregnancy: Historical, Current, and Future Directions
Jones, H. E. (2013) · Substance Abuse · doi:10.1080/08897077.2012.752779 · Cited by 29
Self-citationAdvances in animal models of prenatal opioid exposure
Ferrante, J. R., & Blendy, J. A. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.03.005 · Cited by 27
Xu, K. Y., Jones, H. E., Schiff, D. M., Martin, C. E., Kelly, J. C., Carter, E. B., Bierut, L. J., & Grucza, R. A. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005117 · Cited by 27
Self-citationMaternal and Neonatal Hair and Breast Milk in The Assessment of Perinatal Exposure to Drugs of Abuse
Joya, X., Pacifici, R., Salat‐Batlle, J., García‐Algar, Ó., & Pichini, S. (2015) · Bioanalysis · doi:10.4155/bio.15.60 · Cited by 27
Assessing Neonates for Neonatal Abstinence: Are You Reliable?
D'Apolito, K. (2014) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000056 · Cited by 29
Devlin, L. A., Lau, T. S., & Radmacher, P. G. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00216 · Cited by 27
Postpartum Nurses’ Experience Caring for Infants With Neonatal Abstinence Syndrome
Loyal, J., Nguyen, V., Picagli, D. M., Petrucelli, A. L., O’Mara, E., Grossman, M. R., & Colson, E. R. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2019-0087 · Cited by 27
Development and Validation of a Model to Predict Neonatal Abstinence Syndrome
Patrick, S. W., Slaughter, J. C., Harrell, F. E., Martin, P., Hartmann, K. E., Dudley, J. A., Stratton, S. M., & Cooper, W. O. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.10.030 · Cited by 27
Self-citationWallin, C. M., Bowen, S. E., & Brummelte, S. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106976 · Cited by 27
Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use
Labella, M. H., Eiden, R. D., Tabachnick, A. R., Sellers, T., & Dozier, M. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.107000 · Cited by 26
Kanervo, M. M., Tupola, S. J., Nikkola, E., Rantakari, K. M., & Kahila, H. K. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14497 · Cited by 26
Evaluation and Management of Opioid Dependence in Pregnancy
Park, E. M., Meltzer-Brody, S. E., & Suzuki, J. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.04.003 · Cited by 26
Weimer, M. B., & Chou, R. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.496 · Cited by 26
Neonatal Outcomes in a Medicaid Population With Opioid Dependence
Brogly, S. B., Hernández–Díaz, S., Regan, E., Fadli, E., Hahn, K. A., & Werler, M. M. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx341 · Cited by 26
Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes
Wang, M. J., Kuper, S. G., Sims, B., Paddock, C. S., Dantzler, J., Muir, S., & Harper, L. M. (2018) · American Journal of Perinatology · doi:10.1055/s-0038-1670680 · Cited by 26
Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome
Shrestha, S., Roberts, M. H., Maxwell, J. R., Leeman, L. M., & Bakhireva, L. N. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106975 · Cited by 26
Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas
Meyer, M. C., & Phillips, J. K. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.015 · Cited by 26
Neonatal and longer term management following substance misuse in pregnancy
Mactier, H. (2013) · Early Human Development · doi:10.1016/j.earlhumdev.2013.08.024 · Cited by 26
Jancaitis, B., Kelpin, S. S., Masho, S. W., May, J. C., Haug, N. A., & Svikis, D. S. (2019) · Women & Health · doi:10.1080/03630242.2019.1610829 · Cited by 25
Opioid use disorder in pregnancy
Harter, K. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.11.359 · Cited by 25
Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns
Schubach, N. E., Mehler, K., Roth, B., Korsch, E., Laux, R., Singer, D., der Wense, A. V., Treszl, A., & Hünseler, C. (2016) · European Journal of Pediatrics · doi:10.1007/s00431-016-2716-8 · Cited by 25
Social Determinants of Health: Cultural Competence is Not Enough
Powell, D. L. (2016) · Creative Nursing · doi:10.1891/1078-4535.22.1.5 · Cited by 25
Recent Advances in Drug Addiction Research and Clinical Applications
Meil, W. M., & Ruby, C. L. (2016) · InTech eBooks · doi:10.5772/61445 · Cited by 25
Devlin, L. A., Young, L., Kraft, W. K., Wachman, E. M., Czynski, A. J., Merhar, S. L., Winhusen, T. M., Jones, H. E., Poindexter, B. B., Wakschlag, L. S., et al. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01206-3 · Cited by 25
Self-citationFetal Abnormal Growth Associated With Substance Abuse
Soto, E. E., & Bahado-Singh, R. O. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31827e6b60 · Cited by 25
O’Connor, A. B., Kelly, B. K., & O’Brien, L. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.012 · Cited by 25
Coker, J. L., Catlin, D., Ray-Griffith, S. L., Knight, B. T., & Stowe, Z. N. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.042 · Cited by 25
Janssen, P. A., Demorest, L. C., Kelly, A. M., Thiessen, P. N., & Abrahams, R. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-48 · Cited by 24
Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
Gawronski, K. M., Prasad, M. R., Backes, C. R., Lehman, K. J., Gardner, D. K., & Cordero, L. (2014) · SAGE Open Medicine · doi:10.1177/2050312114530282 · Cited by 24
Opioid Use Disorder in Pregnancy
Roper, V., & Cox, K. J. (2017) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12619 · Cited by 24
Jumah, N. A., Bishop, L. D., Franklyn, M., Gordon, J., Kelly, L., Mamakwa, S., O′Driscoll, T., Olibris, B., Olsen, C., Paavola, N., et al. (2017) · Canadian Journal of Public Health · doi:10.17269/cjph.108.5524 · Cited by 24
Soens, M., He, J., & Bateman, B. T. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.004 · Cited by 24
Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review
Kelty, E. A., & Preen, D. B. (2019) · CNS Drugs · doi:10.1007/s40263-019-00681-9 · Cited by 24
Flannery, T., Davis, J. M., Czynski, A. J., Dansereau, L. M., Oliveira, É. L., Camardo, S. A., & Lester, B. M. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.08.034 · Cited by 24
The Use of Narcotics and Street Drugs During Pregnancy
Lindsay, M. K., & Burnett, E. H. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31827fb6ad · Cited by 24
Buprenorphine Use in Pregnant Opioid Users: A Critical Review
Soyka, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0072-z · Cited by 24
Witsberger, E. M., Cottrell, L., Kiefer, A. S., Yossuck, P., & Malik, A. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1608708 · Cited by 24
Tan, K. Z., Cunningham, A. M., Joshi, A. M., Oei, J. L., & Ward, M. C. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.04.006 · Cited by 24
Austin, A. E., Durrance, C. P., Ahrens, K. A., Chen, Q., Hammerslag, L. R., McDuffie, M. J., Talbert, J., Lanier, P., Donohue, J. M., & Jarlenski, M. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109868 · Cited by 23
Postpartum changes in methadone maintenance dose
Pace, C. A., Kaminetzky, L. B., Winter, M. R., Cheng, D. M., Saia, K., Samet, J. H., & Walley, A. Y. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.04.004 · Cited by 23
Gaalema, D. E., Heil, S. H., Badger, G. J., Metayer, J., & Johnston, A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.06.004 · Cited by 23
Self-citationMehta, D., Thomas, V., Johnson, J., Scott, B., Cortina, S., & Berger, L. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/e163 · Cited by 23
Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes
O’Connor, A. B., O’Brien, L. M., & Alto, W. A. (2015) · European Addiction Research · doi:10.1159/000441220 · Cited by 22
Lander, L. R., Gurka, K. K., Marshalek, P. J., Riffon, M., & Sullivan, C. R. (2015) · Social Work Research · doi:10.1093/swr/svv029 · Cited by 22
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
Dooley, J., Gerber-Finn, L., Antone, I., Guilfoyle, J., Blakelock, B., Balfour-Boehm, J., Hopman, W. M., Jumah, N. A., & Kelly, L. (2016) · Europe PMC (PubMed Central) · Cited by 22
Treatments for opioid use disorder among pregnant and reproductive-aged women
Hand, D. J., Short, V. L., & Abatemarco, D. J. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.011 · Cited by 22
Kelty, E. A., & Hulse, G. K. (2017) · American Journal on Addictions · doi:10.1111/ajad.12642 · Cited by 22
Miller, C. D., Grynspan, D., Gaudet, L., Ferretti, E., Lawrence, S. L., Moretti, F., Lafreniere, A. J., McGee, A., Lattuca, S., & Black, A. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000478 · Cited by 22
Griffin, B. A., Caperton, C. O., Russell, L. N., Cabanlong, C. V., Wilson, C. D., Urquhart, K. R., Martins, B. S., Zita, M. D., Patton, A. L., Alund, A. W., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254219 · Cited by 22
How long should infants at risk of drug withdrawal be monitored after birth?
Smirk, C., Bowman, E., Doyle, L. W., & Kamlin, C. O. F. (2014) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12513 · Cited by 22
Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007‐2013
Stabler, M. E., Long, D. L., Chertok, I. R. A., Giacobbi, P. R., Pilkerton, C. S., & Lander, L. R. (2016) · The Journal of Rural Health · doi:10.1111/jrh.12174 · Cited by 21
Sadée, W., Oberdick, J., & Wang, Z. J. (2020) · Molecules · doi:10.3390/molecules25184163 · Cited by 21
A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
Seguí, H. A., Melín, K., Santiago, D., & Duconge-Soler, J. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.35 · Cited by 22
Premkumar, A., Grobman, W. A., Terplan, M., & Miller, E. S. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003503 · Cited by 21
Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
Merhar, S. L., Ounpraseuth, S., Devlin, L. A., Poindexter, B. B., Young, L., Berkey, S. D., Crowley, M. A., Czynski, A. J., Kiefer, A. S., Whalen, B. L., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-017830 · Cited by 21
Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study
Plouffe, R., Grywacheski, V., Luo, W., Nelson, C. R. M., & Orpana, H. (2022) · Canadian Journal of Public Health · doi:10.17269/s41997-022-00726-5 · Cited by 20
Straub, L., Bateman, B. T., Hernández–Díaz, S., Zhu, Y., Suarez, E. A., Vine, S. M., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., et al. (2024) · JAMA · doi:10.1001/jama.2024.11501 · Cited by 20
Self-citationLim, G., Carvalho, B., George, R. B., Bateman, B. T., Brummett, C. M., Ip, V. H. Y., Landau, R., Osmundson, S. S., Raymond, B. L., Richebé, P., et al. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007237 · Cited by 22
Methadone and Metabolites in Hair of Methadone-Assisted Pregnant Women and Their Infants
Himes, S. K., Goodwin, R. S., Rock, C., Jones, H. E., Johnson, R. E., Wilkins, D. G., & Huestis, M. A. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182512b26 · Cited by 20
Self-citationLund, I. O., Brendryen, H., & Ravndal, E. (2014) · Substance Abuse Research and Treatment · doi:10.4137/sart.s15055 · Cited by 20
Sensorimotor outcomes in children with prenatal exposure to methadone
Yoo, S. H., Jansson, L. M., & Park, H.-J. (2017) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2017.05.025 · Cited by 20
A Practical Approach to Neonatal Opiate Withdrawal Syndrome
Davis, J. M., & Devlin, L. A. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1608630 · Cited by 20
Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
Wong, J. J., Saver, B. G., Scanlan, J. M., Gianutsos, L. P., Bhakta, Y., Walsh, J., Plawman, A., Sapienza, D., & Rudolf, V. P. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000427 · Cited by 20
Salivary cortisol levels as a biomarker for severity of withdrawal in opioid-exposed newborns
Rodríguez, N., Vining, M. A., & Bloch‐Salisbury, E. (2019) · Pediatric Research · doi:10.1038/s41390-019-0601-7 · Cited by 20
Camerota, M., Davis, J. M., Dansereau, L. M., Oliveira, É. L., Padbury, J. F., & Lester, B. M. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.12.057 · Cited by 20
Petrich, M. R., Battin, M., Walker, E., Brown, M. D., Abdelwahab, M., Ma’ayeh, M., & Rood, K. M. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2130238 · Cited by 20
McNicholas, L. F., Holbrook, A. M., O’Grady, K. E., Jones, H. E., Coyle, M. G., Martin, P., Heil, S. H., Stine, S. M., & Kaltenbach, K. A. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04043.x · Cited by 20
Self-citationPerinatal outcomes of A ustralian buprenorphine‐exposed mothers and their newborn infants
Patel, P., Abdellatif, M., Hazelton, B. J., WODAK, A. D., Chen, J., Emsley, F., Feller, J. M., Lui, K., & Oei, J. L. (2013) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12264 · Cited by 20
The management of opioid dependence during pregnancy in rural and remote settings
Jumah, N. A., Graves, L. E., & Kahan, M. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131723 · Cited by 20
Breastfeeding and Opiate Substitution Therapy: Starting to Understand Infant Feeding Choices
Graves, L. E., Turner, S., Nader, M., & Sinha, S. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s34553 · Cited by 20
The role of mother-infant bond in neonatal abstinence syndrome (NAS) management
Kondili, E., & Duryea, D. G. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2019.02.003 · Cited by 20
Holbrook, A. M., Jones, H. E., Heil, S. H., Martin, P., Stine, S. M., Fischer, G., Coyle, M. G., & Kaltenbach, K. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.031 · Cited by 20
Self-citationPain medication use during pregnancy
Nunge, R. A., Kendle, A. M., & Alwan, S. S. (2025) · Seminars in Perinatology · doi:10.1016/j.semperi.2025.152074 · Cited by 19
Turner, S., Allen, V. M., Carson, G., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.012 · Cited by 20
Developmental Outcomes after Opioid Exposure in the Fetus and Neonate
Fong, J., Lewis, J., Lam, M., & Kesavan, K. (2024) · NeoReviews · doi:10.1542/neo.25-6-e325 · Cited by 19
Whitham, J. N., Spurrier, N. J., Baghurst, P., Weston, P. F., & SAWYER, M. G. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.09.008 · Cited by 19
Kahn, L. S., Mendel, W. E., Fallin, K. L., Borngraber, E., Nochajski, T. H., Rea, W. E., & Blondell, R. D. (2017) · Social Work in Health Care · doi:10.1080/00981389.2017.1327470 · Cited by 19
Lappen, J. R., Stark, S., Bailit, J. L., & Gibson, K. S. (2019) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2019.100075 · Cited by 19
Bakhireva, L. N., Sparks, A., Herman, M. P., Hund, L., Ashley, M., & Salisbury, A. L. (2021) · Pediatric Research · doi:10.1038/s41390-021-01756-4 · Cited by 19
Elam, H. B., Donegan, J. J., Hsieh, J., & Lodge, D. J. (2022) · eNeuro · doi:10.1523/eneuro.0499-21.2022 · Cited by 19
Chin, E. M., Kitase, Y., Madurai, N. K., Robinson, S., & Jantzie, L. L. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1139378 · Cited by 19
Barber, C. M., & Terplan, M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1045745 · Cited by 19
Neonatal abstinence syndrome: where are we, and where do we go from here?
Brandt, L., & Finnegan, L. P. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000334 · Cited by 19
Coulson, C. C., Lorencz, E., Rittenhouse, K., Ramage, M., Lorenz, K., & Galvin, S. L. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1694729 · Cited by 19
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.